Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Division of Cardiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
J Am Coll Cardiol. 2021 Jun 1;77(21):2625-2634. doi: 10.1016/j.jacc.2021.03.320.
The DASH (Dietary Approaches to Stop Hypertension) diet has been determined to have beneficial effects on cardiac biomarkers. The effects of sodium reduction on cardiac biomarkers, alone or combined with the DASH diet, are unknown.
The purpose of this study was to determine the effects of sodium reduction and the DASH diet, alone or combined, on biomarkers of cardiac injury, strain, and inflammation.
DASH-Sodium was a controlled feeding study in adults with systolic blood pressure (BP) 120 to 159 mm Hg and diastolic BP 80 to 95 mm Hg, randomly assigned to the DASH diet or a control diet. On their assigned diet, participants consumed each of three sodium levels for 4 weeks. Body weight was kept constant. At the 2,100 kcal level, the 3 sodium levels were low (50 mmol/day), medium (100 mmol/day), and high (150 mmol/day). Outcomes were 3 cardiac biomarkers: high-sensitivity cardiac troponin I (hs-cTnI) (measure of cardiac injury), N-terminal pro-B-type natriuretic peptide (NT-proBNP) (measure of strain), and high-sensitivity C-reactive protein (hs-CRP) (measure of inflammation), collected at baseline and at the end of each feeding period.
Of the original 412 participants, the mean age was 48 years; 56% were women, and 56% were Black. Mean baseline systolic/diastolic BP was 135/86 mm Hg. DASH (vs. control) reduced hs-cTnI by 18% (95% confidence interval [CI]: -27% to -7%) and hs-CRP by 13% (95% CI: -24% to -1%), but not NT-proBNP. In contrast, lowering sodium from high to low levels reduced NT-proBNP independently of diet (19%; 95% CI: -24% to -14%), but did not alter hs-cTnI and mildly increased hs-CRP (9%; 95% CI: 0.4% to 18%). Combining DASH with sodium reduction lowered hs-cTnI by 20% (95% CI: -31% to -7%) and NT-proBNP by 23% (95% CI: -32% to -12%), whereas hs-CRP was not significantly changed (-7%; 95% CI: -22% to 9%) compared with the high sodium-control diet.
Combining a DASH dietary pattern with sodium reduction can lower 2 distinct mechanisms of subclinical cardiac damage: injury and strain, whereas DASH alone reduced inflammation. (Dietary Patterns, Sodium Intake and Blood Pressure [DASH - Sodium]; NCT00000608).
DASH(停止高血压的饮食方法)饮食已被确定对心脏生物标志物具有有益的影响。单独减少钠或与 DASH 饮食联合减少钠对心脏生物标志物的影响尚不清楚。
本研究旨在确定单独减少钠或与 DASH 饮食联合减少钠对心脏损伤、应变和炎症的生物标志物的影响。
DASH-钠是一项在收缩压 120-159 mmHg 和舒张压 80-95 mmHg 的成年人中进行的对照喂养研究,随机分配到 DASH 饮食或对照饮食。在他们指定的饮食中,参与者每 4 周食用三种不同的钠水平中的一种。保持体重不变。在 2200 千卡水平时,三种钠水平分别为低(50 mmol/天)、中(100 mmol/天)和高(150 mmol/天)。结果是三种心脏生物标志物:高敏心肌肌钙蛋白 I(hs-cTnI)(心脏损伤标志物)、N 末端 pro-B 型利钠肽(NT-proBNP)(应变标志物)和高敏 C 反应蛋白(hs-CRP)(炎症标志物),在基线和每个喂养期结束时收集。
在最初的 412 名参与者中,平均年龄为 48 岁;56%为女性,56%为黑人。平均基线收缩压/舒张压为 135/86 mmHg。与对照组相比,DASH(与对照组相比)降低了 18%的 hs-cTnI(95%置信区间:-27%至-7%)和 13%的 hs-CRP(95%置信区间:-24%至-1%),但不降低 NT-proBNP。相比之下,从高钠水平降低至低钠水平独立于饮食降低了 NT-proBNP(19%;95%置信区间:-24%至-14%),但不改变 hs-cTnI,轻度增加 hs-CRP(9%;95%置信区间:0.4%至 18%)。DASH 与钠减少联合使用可使 hs-cTnI 降低 20%(95%置信区间:-31%至-7%)和 NT-proBNP 降低 23%(95%置信区间:-32%至-12%),而 hs-CRP 与高钠对照组相比无明显变化(-7%;95%置信区间:-22%至 9%)。
DASH 饮食模式与钠减少相结合可降低两种不同的亚临床心脏损伤机制:损伤和应变,而 DASH 单独降低炎症。(饮食模式、钠摄入量和血压 [DASH-钠];NCT00000608)。